Translations:Sulbutiamine/10/en
Jump to navigation
Jump to search
It was first marketed in France by Servier in 1973 under the brand name Arcalion. The drug registration went through a validation procedure in France in the 1980s, which found that the use for treatment of fatigue was not supported by data. In January 1989, 100 mg tablet doses were discontinued in favour of 200 mg tablets.